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AbstrAct
Objectives Poorly controlled type 2 diabetes mellitus 
(T2DM) is a major international health problem. Our 
aim was to assess the effectiveness of healthcare 
interventions, specifically targeting patients with poorly 
controlled T2DM, which seek to improve glycaemic control 
and cardiovascular risk in primary care settings.
Design Systematic review.
setting Primary care and community settings.
Included studies Randomised controlled trials (RCTs) 
targeting patients with poor glycaemic control were 
identified from Pubmed, Embase, Web of Science, 
Cochrane Library and SCOPUS. Poor glycaemic control was 
defined as HbA1c over 59 mmol/mol (7.5%).
Interventions Interventions were classified as 
organisational, patient-oriented, professional, financial or 
regulatory.
Outcomes Primary outcomes were HbA1c, blood pressure 
and lipid control. Two reviewers independently assessed 
studies for eligibility, extracted data and assessed study 
quality. Meta-analyses were undertaken where appropriate 
using random-effects models. Subgroup analysis explored 
the effects of intervention type, baseline HbA1c, study 
quality and study duration. Meta-regression analyses were 
undertaken to investigate identified heterogeneity.
results Forty-two RCTs were identified, including 11 250 
patients, with most undertaken in USA. In general, studies 
had low risk of bias. The main intervention types were 
patient-directed (48%) and organisational (48%). Overall, 
interventions reduced HbA1c by −0.34% (95% CI −0.46% 
to −0.22%), but meta-analyses had high statistical 
heterogeneity. Subgroup analyses suggested that 
organisational interventions and interventions on those 
with baseline HbA1c over 9.5% had better improvements 
in HbA1c. Meta-regression analyses suggested that 
only interventions on those with population HbA1c over 
9.5% were more effective. Interventions had a modest 
improvement of blood pressure and lipids, although 
baseline levels of control were generally good.
conclusions This review suggests that interventions for 
T2DM, in primary care, are better targeted at individuals 
with very poor glycaemic control and that organisational 
interventions may be more effective.
IntrODuctIOn
Worldwide, type 2 diabetes mellitus (T2DM) 
is rising in prevalence and will exceed 4.4% 
of the world’s population or 366 million by 
2030.1 Despite a wealth of evidence regarding 
the importance of risk factor control in T2DM, 
many patients continue to have poor control 
of HbA1c, blood pressure and lipids. Up to 
60% of the patients fail to meet target HbA1c 
levels.2 Similarly, over one-third of the patients 
with T2DM have inadequate blood pressure 
control.3 Poorly controlled T2DM—and its 
associated microvascular and macrovascular 
complications—is associated with higher 
morbidity, higher mortality, poorer quality of 
life and substantial economic burden.4
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Research
strengths and limitations of the study
 ► This systematic review adds to the evidence 
regarding the effectiveness of healthcare 
interventions, which specifically target patients with 
poor glycaemic control of type 2 diabetes mellitus, in 
community settings.
 ► There is no specific definition for ‘poor control’ 
diabetes in the literature, but by including all studies 
that had patients with a HbA1c  ≥59 mmol/mol 
(7.5%), we captured the full range of poor glycaemic 
control and also examined other key risk factors 
such as blood pressure and lipids.
 ► Data were pooled from 42 studies across four 
continents, enhancing the generalisability of the 
findings.
 ► We did not account for medication use in the studies, 
but given that all included studies were randomised 
controlled trials, which would balance out delivery of 
medications, we think that differences in underlying 
medication usage may relate to how different 
interventions promote intensification of medications.
 ► An individual patient data meta-analysis may 
answer further questions not possible in this review.
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Several studies have examined interventions designed 
to support the delivery of diabetes care in the commu-
nity to improve glycaemic and cardiovascular risk factor 
control.5–11 A 2011 review of community-based interven-
tions including all patients with T2DM, comprising 68 
studies, showed that only one-third had a statistically 
significant improvement in one of the relevant clin-
ical outcomes for diabetes: HbA1c, blood pressure or 
lipids.8 The majority of the included studies targeted 
all patients with T2DM without focussing on those with 
poor control. Although no overall effect was noted, 
combining organisational with professional (multifac-
eted) interventions was concluded to be more beneficial 
than single interventions and the highest quality multi-
faceted randomised controlled trials (RCTs) tended to 
include decision support interventions and elements. 
A 2013 review looked at 48 cluster RCTs, assessing the 
effectiveness of quality improvement (QI) strategies on 
the management of diabetes (both T1DM and T2DM).11 
It suggested that QI interventions, which intervened at 
a system level on diabetes management, were associated 
with the largest benefits in glycaemic control and that the 
effectiveness of interventions targeting healthcare prac-
titioners varied with baseline glycaemic control, being 
more effective with patients with worse control.11 A 2016 
review, of T1DM or T2DM in primary care, looked at 
the effects of Clinician Education, Clinician Reminders, 
Team Changes, Case Management, Electronic Patient 
Registry, Telemedicine and Audit and Feedback.10 
Including 30 studies, it concluded that multifaceted 
interventions on multidisciplinary teams were most effec-
tive. Interventions targeting family physicians were only 
effective if computerised feedback on insulin prescribing 
was provided.
Four large RCTs from North America and the UK have 
investigated the effects of intensive management of hyper-
glycaemic and cardiac risk factors on mortality in T2DM 
across all settings.12–17 Uncertainty remains regarding 
intensive glycaemic management for all patients with 
T2DM, with concerns about aggressive reductions in 
HbA1c.18 Targeted reductions in cardiovascular and 
glycaemic risk factors in certain vulnerable populations 
(cognitively impaired, disabled and frail) have been advo-
cated.19 Interventions that specifically target those with 
very poor control of risk factors may be more beneficial 
than those targeting all patients, achieving the benefits 
of cardiovascular and glycaemic control, but without 
the potential risks of intensively lowering HbA1c in all 
persons with T2DM. The effect of interventions specifi-
cally targeting patients with poorly controlled T2DM in 
primary care is unknown.
Our aim was to assess the effectiveness of healthcare 
interventions delivered in primary care and commu-
nity settings, targeting poorly controlled T2DM, which 
seek to improve glycaemic control, blood pressure and 
lipids.
MethODs
The Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidelines were used to 
standardise the conduct and reporting of the research 
and the protocol was registered on PROSPERO.20
Data sources and searches
We searched articles in all languages from the Cochrane 
Library, Pubmed, Embase, Web of Science and SCOPUS 
from 1990 to 31 December 2016. Reference lists of all 
included papers were searched. Secondary searching 
of all references from included studies was also 
conducted.  Online supplementary appendix 1 outlines 
the search string.
study selection
We considered RCTs, controlled clinical trials, controlled 
before and after studies and interrupted time series 
analyses meeting the Cochrane Effective Practice and 
Organisation of Care (EPOC) quality criteria.21 Studies 
published in all languages were eligible.
Population
Individuals with ‘poorly controlled’ T2DM were our 
population of interest. Though there is a broad consensus 
about the importance of achieving good glycaemic 
control for the reasons described, there are no validated 
cut-offs, which define ‘poor-control’ of T2DM for targeted 
interventions. Poorly controlled T2DM has been defined 
based on elevated glycated haemoglobin levels in the 
literature, with different thresholds of HbA1c described, 
from over 59 mmol/mol (7.5%), over 64 mmol/mol 
(8.0%) to over 75 mmol/mol (9.0%).22–24 In this review, 
we considered participants to have poorly controlled 
T2DM if their HbA1c was over 59 mmol/mol (7.5%) (or 
if over 80% of the population in a study had a HbA1c over 
59 mmol/mol). Similarly, there is no defined cut-off as to 
what defines ‘poorly controlled’ blood pressure. We iden-
tified studies primarily based on poor glycaemic control 
and also included participants in these studies who had 
uncontrolled hypertension or elevated cholesterol/
lipids, if the risk factor level was above that of an accepted 
international target, as designated by the study authors. 
Where studies included patients with ‘poor control’ based 
on a range of risk factor profiles, for consistency, we only 
included a study if 80% of the population had a HbA1c 
over 59 mmol/mol (7.5%).
Interventions
We included interventions delivered by healthcare profes-
sionals specifically aiming to target patients with poor 
control of T2DM, based in primary care or community 
settings. The primary healthcare setting was defined as 
providing ‘integrated, easy to access, healthcare services 
by clinicians who are accountable for addressing a large 
majority of personal healthcare needs, developing a 
sustained and continuous relationship with patients and 
practicing in the context of family and community’.25 We 
excluded drug trials though interventions could have 
involved treatment intensification. Interventions were 
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defined as simple if they had one identifiable component 
and multifaceted if they had more than one element. We 
excluded trials performed within the hospital or the hospi-
tal-outpatient setting. The Cochrane EPOC taxonomy 
of interventions was used and the predominant inter-
vention type was defined using five categories including 
organisational, patient-centred, regulatory, financial and 
professional. Examples of these intervention types are 
provided in online supplementary appendix 2.21
Comparison
Comparison groups were included if they received usual 
care in that setting for T2DM. Controls were also included 
if they received minor enhanced elements of care, such as 
education leaflets, which the study authors believed did 
not go beyond usual care in most settings.
Outcome measures
Primary outcomes included glycaemic control (HbA1c), 
blood pressure (systolic or diastolic) and lipid levels, but 
if studies did not include HbA1c, they were excluded. 
Secondary outcomes included patient-reported outcome 
measures (PROMs) (eg, health-related quality of life), 
utilisation of health services, behavioural outcomes such 
as medication adherence, provider behaviour, accept-
ability of service to patients and providers, economic 
outcomes and adverse events.
Data extraction and quality assessment
Two reviewers (MEM and RG) read the titles and/or 
abstracts of the identified references and eliminated 
irrelevant studies. Studies that were deemed eligible for 
inclusion were read in full and their suitability for inclusion 
in the systematic review was independently determined by 
two reviewers. Disagreements were managed by a third, 
independent reviewer (SMS). The following information 
was extracted: (a) details of intervention, (b) partici-
pants, (c) clinical setting, (d) study design, (e) outcomes, 
(f) author information. We contacted authors for missing 
data.
Risk of bias in articles was assessed using the Cochrane 
Handbook for systematic reviewing and EPOC criteria.26 
Two review authors independently assessed the risk of 
bias of each included study against the criteria described 
in the Cochrane risk of bias tool. We explicitly judged 
each of these criteria using: low risk of bias, high risk of 
bias or unclear risk of bias (either lack of information 
or uncertainty over the potential for bias). We resolved 
disagreements by consensus and consulted a third review 
author to resolve disagreements if necessary. An overall 
assessment of a study’s risk of bias was determined using 
EPOC guidance, with judgement and consensus reached 
between two reviewers (MEM and SMS).26
Data analysis
For continuous data, we calculated the treatment effect 
using mean differences (MDs) and 95% CIs. No binary 
outcomes were included. Revman software was used 
to perform the analysis, determine heterogeneity and 
produce forest plots to illustrate pooled estimates.21 
Stata version 13 was used to investigate publication bias 
by creating funnel plots and using Egger’s test to assess 
funnel plot asymmetry.27 A random-effects analysis was 
performed and heterogeneity across the studies was 
quantified using the I2 statistic. The I2 statistic describes 
the percentage of the variability in effect estimates which 
is due to heterogeneity rather than sampling error 
(chance).28 If the I2 statistic was >50%, it was deemed that 
there was significant heterogeneity between the studies.
Subgroup analyses were performed for primary 
outcomes based on a priori assumptions, as per the 
PROSPERO protocol.20 For HbA1c, we explored the 
possible effects of subgroups: (a) the type of intervention 
based on the EPOC taxonomy (see online supplemen-
tary appendix 2); (b) study quality and (c) baseline HbA1c 
in the study populations (HbA1c 7.5%–9.4% or ≥9.5%). 
After reviewing, the included studies we also included 
study duration as a subgroup (<12 months or ≥12 
months), as a wide range in study duration was found. 
Subgroup analyses for systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) explored the effects of 
intervention-type based on the EPOC taxonomy.
When important heterogeneity was identified, we inves-
tigated its causes using meta-regression. Meta-regression 
is an extension to subgroup analysis that allows the effect 
of continuous, as well as categorical, characteristics to be 
investigated.29 Meta-regression was performed to explore 
the effects of: (a) study quality (using the overall assess-
ment risk of bias); (b) study population characteristics 
(eg, gender, age and baseline HbA1c and SBP); (c) inter-
vention type (EPOC taxonomy) and (d) study duration 
on the primary outcomes.29 Random effects meta-regres-
sion was performed using Stata version 13.27
results
Overall 18 829 titles were screened and 42 full text arti-
cles met the inclusion criteria (figure 1: PRISMA flow 
diagram). All 42 studies were RCTs, encompassing 50 
interventions in total, comprising 11 250 patients.22–24 30–68 
No other eligible study designs were identified.
characteristics of studies
Twenty-nine of the 42 studies were conducted in USA, 9 in 
Europe, 2 in Australia, 1 in Mexico and 1 in Israel. Follow-up 
of outcomes in the studies varied in length from 353 to 36 
months.46 The mean HbA1c at baseline across all studies 
was 9.5% (95% CI 9.3% to 9.8%). The mean age of patients 
in the studies was 58.0, varying from 47.9 (62) to 67.5 
(41) partly reflecting different inclusion criteria (table 1). 
Thirty studies explicitly defined their study population as 
‘poorly controlled’, ‘complicated’ or ‘persistently poorly 
controlled’, whereas the other 12 had poorly controlled 
T2DM with HbA1c ≥59 mmol/mol (7.5%) as per the review 
inclusion criteria. Twenty-seven of the 42 studies reported 
SBP results22–24 30–36 38 39 41 45 46 48–51 54 58–60 62 65 66 68 and of 
these, 23 reported DBP.22–24 31 32 34–36 38 39 41 45 46 48 49 51 54 58 59 
62 65 66 68 Twenty of the studies reported a lipid outcome.23 
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Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow sheet.
24 30–32 35 36 38 39 41 45 46 48 51 56 58 62 65 66 68 All of the 42 studies 
reported at least one secondary outcome. Two studies were 
excluded from primary outcome analysis due to lack of 
appropriate data, despite efforts to contact authors.31 61
Interventions were all complex with multiple compo-
nents. Studies were categorised based on the predominant 
intervention element using the EPOC taxonomy. The 
included interventions were categorised as predominantly 
patient-centred (n=20, 48%), organisational (n=20, 48%), 
financial (n=1, 2%) or professional (n=1, 2%). One study44 
comprised two intervention arms with a patient-centred 
and financial intervention (included as a patient-centred 
predominant intervention in our analysis). Descriptions of 
the interventions are outlined in table 1.
The 20 patient-centred interventions in our review 
included 4 telephone-based,34 41 56 58 5 computerised/
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mobile phone-based,32 36 52 61 68 1 video-based,51 5 peer-
support-based,30 38 44 49 65 3 self-monitoring-based37 50 64 
and 2 -culturally supportive self-management inter-
ventions.39 45 The 20 organisational interventions 
included 5 pharmacist interventions performing case 
management,35 40 47 48 57 6 nurse case management interven-
tions,23 31 46 53 55 60 3 web-based/telemedicine/telephone 
case management interventions,24 59 63 3 new-clinic-based 
interventions,43 54 66 1 community health-worker inter-
vention,62 1 psychological intervention22 and 1 lay 
health worker intervention.67 Eight interventions had an 
mHealth or telehealth component.33 36 45 52 56 59 65 68 More 
detailed descriptions of the interventions are outlined in 
online supplementary appendix 3.
risk of bias
All 42 studies were RCTs, with six being cluster RCTs. 
Overall, 25 studies were classified as having a predomi-
nant low-risk of bias (59.5%),22–24 32–36 39 41 42 45 46 51 53–55 58 
59 62–66 68 13 studies had an unclear-risk (31%)30 31 37 38 40 44 
47 49 56 57 60 61 67 and 4 RCTs were classified as having a high-
risk of bias (9.5%)43 48 50 52 (see online supplementary 
appendix 4). Blinding of outcome assessment was classi-
fied as low-risk in all studies. Attrition bias was evident in 
seven studies. Online supplementary appendix 5 outlines 
the summary judgements for both overall risk of bias and 
predominant intervention type, which were used in the 
meta-regression analysis.
There was no evidence of publication bias in the studies 
included in the HbA1c (p=0.37) or SBP analysis (p=0.54). 
However, there was some evidence of publication bias in 
the studies included in the DBP analysis (p<0.01) (see 
online supplementary appendixes 6(a) and  6(b)).
Primary outcomes
HbA1c
Overall 40 of the 42 studies were included in a meta-anal-
ysis, which found a MD in HbA1c of −3.7 mmol/mol 
(−0.34%; 95% CI −0.46% to −0.22%) favouring interven-
tion groups, but with statistical heterogeneity (I2=69%). 
Figure 2A outlines the overall effect of interventions on 
HbA1c, across EPOC categories.
Subgroup analyses were performed based on the 
predominant intervention type (figure 2A), the baseline 
HbA1c level (figure 2B), study duration (figure 2C) and 
study quality (figure 2D).
These analyses suggested that organisational interven-
tions (MD in HbA1c of −5.2 mmol/mol (−0.42%; 95% CI 
−0.66% to −0.18%; I2=79%) had better improvements 
in HbA1c than patient-centred interventions (−0.30%; 
95% CI −0.43% to −0.18%; I2=48%) (p=0.05). Similarly 
interventions performed when the baseline popula-
tion-HbA1c was over 80 mmol/mol (9.5%) (MD in HbA1c 
of −6.3 mmol/mol (−0.58%; 95% CI −0.81% to −0.35%; 
I2=75%) had better improvements in HbA1c than popu-
lations with a baseline-HbA1c<9.5% (−0.17%%; 95% CI 
−0.29% to −0.05%%; I2=51%) (p=0.002). Study duration 
did not appear to affect HbA1c (figure 2C). Lastly, studies 
with a low-risk of bias (MD in HbA1c was −2.8 mmol/mol 
(−0.26%; 95% CI −0.39% to −0.13%; I2=59%) appeared 
to have a smaller reduction in HbA1c compared with 
unclear (−0.49%%; 95% CI −0.84%% to −0.15%; I2=81%) 
and high-risk studies (−0.41%; 95% CI −0.74% to −0.09%; 
I2=61%), but there was no evidence of a statistically signif-
icant difference (p=0.35). Though not considered in our 
original protocol, subgroup analysis did not highlight 
additional benefit from those interventions (included 
in both organisational and patient-centred intervention 
types), which had a telemedicine or mHealth component 
(see online supplementary appendix 7).33 36 45 52 56 59 65 68
As the overall results showed statistical heteroge-
neity, meta-regression analysis was also conducted to 
explore the components of this heterogeneity. As with 
the meta-analyses, higher baseline HbA1c was associated 
with a greater reduction in HbA1c (β-Coefficient: −0.27; 
95% CI −0.41 to –0.13; p<0.001). The predominant-in-
tervention type, risk of bias and study-duration were not 
associated with improved glycaemic control.
Blood pressure
Overall there was small improvement in SBP in the 26 
interventions included in the meta-analysis, (MD SBP: 
–1.13 mm Hg (95% CI −2.19 to –0.08)) with moderate 
heterogeneity (I2=47%) (see online supplementary 
appendix 8).22–24 30–36 38 39 41 45 46 48–51 54 58–60 62 65 66 68 
DBP improved modestly in the 22 studies included in 
the meta-analysis (MD DBP: –1.37 mm Hg (95% CI 
−2.25 to –0.50)) with moderate heterogeneity (I2=44%) 
(see online supplementary appendix 9).22–24 31 32 34–36 38 39 
41 45 46 48 49 51 54 58 59 62 65 66 68
In the subgroup analysis, organisational inter-
ventions appeared to improve SBP modestly (MD 
SBP: –2.69 mm Hg; 95% CI −5.11 to –0.26; I2=57%) 
compared with patient-centred interventions (MD 
SBP: –0.52 mm Hg; 95% CI −1.41 to 0.38; I2=20%) 
which showed no statistically significant improvement 
(see online supplementary appendix 8). However, 
there was no evidence of a statistically significant differ-
ence between intervention types. Similarly with DBP, 
organisational interventions appeared to improve DBP 
modestly (MD DBP: −2.87 mm Hg; 95% CI −4.29 to –1.45; 
I2=30%) compared with patient-centred interventions 
(MD DBP: −1.37 mm Hg; 95% CI −1.42 to 0.2; I2=30%) 
(see online supplementary appendix 9) and there was 
evidence of a statistically significant difference (p=0.007). 
Meta-regression analysis was not conducted for SBP or 
DBP, as significant heterogeneity was not present on the 
overall effect sizes.
Lipids
Twenty of the 42 studies reported total choles-
terol,  low-density lipoprotein cholesterol,  high-density 
lipoprotein cholesterol or triacylglicerides.23 24 30–32 35 36 
38 39 41 45 46 48 51 56 58 62 65 66 68 Statistically significant improve-
ments in lipids were only demonstrated in 4 of these 20 
studies.31 32 45 48 Baseline lipid levels were generally not 
reported. Eleven of the 20 studies reported data relating 
to total cholesterol. Meta-analysis was undertaken on 
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Figure 2A Effects of interventions on HbA1c, with intervention-type subgroups.
these studies, which indicated a modest improvement 
in total cholesterol, favouring intervention groups (MD 
total cholesterol – 4.29 mg/dL (95% CI −7.68 to –0.89); 
I2=0%) (see online supplementary appendix 10).35 36 38 
41 45 46 58 62 65 66 68
secondary outcomes
All but 1 of the 42 included studies reported at least one 
of the eligible secondary outcomes (see online supple-
mentary appendix 11). Overall, interventions had 
very limited effect on secondary outcomes. Twenty-six 
studies reported other physical outcomes (eg, body mass 
index (BMI) and estimated glomerular filtration rate). Of 
the 15 studies that reported on weight or BMI, only one 
showed significant improvement.56 Ten studies reported 
mental health outcomes36 38 41 45 58 59 64 with two showing 
a significant improvement in the Change Mental Compo-
nent Summary Score and the Short Form-12 Mental 
Health Score.64 67 Twenty-eight studies reported PROMs, 
with 11 showing an improvement with the intervention. 
Ten studies reported medication adherence outcomes, 
with two showing improvement. Eighteen studies reported 
utilisation outcomes, with four improving processes of 
care.
DIscussIOn
Statement of principle findings
Healthcare interventions have positive, although modest, 
effects on HbA1c in poorly controlled T2DM. Inter-
ventions targeting those with a higher baseline HbA1c 
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Figure 2B Effects of interventions on HbA1c, with baseline HbA1c subgroup.
(≥80 mmol/mol (9.5%)) show the greatest effects. There 
was also evidence of a modest impact on both blood 
pressure and lipids, though baseline control of these 
risk factors was generally good. Generally, little effect on 
secondary outcomes was found. Our results suggest that 
a targeted approach to T2DM management, focussing on 
individuals with very poor glycaemic control, may repre-
sent a prudent strategy for future management.
strengths and weaknesses of the study
The methodology of our systematic review addresses key 
credibility issues.69 70 The research question was sensible, 
our search of the literature was exhaustive and our results 
are outlined clearly for primary and secondary outcomes. 
The effect of baseline HbA1c was consistent across studies, 
biologically plausible and was an a priori hypothesis.70
We performed meta-regression to explore the hetero-
geneity, which also confirmed the increased effectiveness 
of interventions on those with HbA1c ≥80 mmol/mol 
(9.5%). However, a major limitation is that meta-regres-
sion is usually underpowered to detect anything but 
very large associations. Meta-regression considers the 
interactions between trial level covariates and the treat-
ment effect, but it inherits difficulties of interpretation 
attached to non-randomised studies, as it is not possible 
to randomise patients to one covariate value or another, 
so causality cannot be attached its findings.71 Though we 
do not believe the subgroup findings occurred by chance, 
there remained high heterogeneity and we explored 
between-study comparisons rather than within-study 
comparisons.70 There was some evidence of publication 
bias in the DBP analysis, but this was not present for the 
22 studies reporting SBP. It should also be noted that the 
power of Egger’s test is low when the number of studies 
is small and should only be used if the analysis includes a 
range of study sizes.
This study will inform researchers regarding the 
range of interventions that have been deployed to 
target patients with poorly controlled T2DM. There is 
no specific definition for ‘poor control’ of T2DM in the 
literature, but by including all studies that had patients 
with a HbA1c >59 mmol/mol (7.5%), we captured the full 
range of poor glycaemic control. Studies examining poor 
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Figure 2C Effects of interventions on HbA1c, with baseline study duration subgroups.
control of HbA1c possess a risk of regression towards 
the mean. However, all included studies were RCTs with 
control groups, which should have accounted for this. 
Targeted interventions in poorly controlled T2DM need to 
be distinguished from interventions, which are designed 
to intensively reduce HbA1c in all patients. Though 
persons with very poor glycaemic control are also at risk 
of the adverse effects of hypoglycaemic agents, targeting 
this population is more likely to reach the right balance 
of reducing harms of overtreatment and maximising 
potential benefits.18 The relative importance of targeting 
glycaemic or cardiovascular risk has been debated in the 
literature.17 We did not account for medication use in the 
studies, but given that all included studies were RCTs, 
which would balance out delivery of medications, we 
think that differences relating to underlying medication 
usage relate to how different interventions types promote 
the intensification of medications.
comparison with other studies
The existing literature examining healthcare interven-
tions to improve glycaemic control has focused on a 
range of approaches. There have been systematic reviews 
of interventions including QI initiatives, education, 
self-management support, case-management, adherence 
to medication and professional interventions, though as 
outlined previously, most have not specifically targeted 
patients with poor glycaemic control.8 10 11
A synthesis of 27 systematic reviews and 347 RCTs 
identified the cost-effectiveness of self-management 
interventions in T2DM in all patients with T2DM.72 This 
overview included studies that targeted all patients with 
T2DM and found very good evidence that education 
improves blood glucose control in patients with T2DM in 
the short term (less than 12 months) and that behavioural 
and psychological interventions are associated with modest 
improvements in blood glucose control (HbA1C).72 73 
A review of computer-based diabetes self-management 
interventions to manage T2DM reported a small bene-
ficial effect on blood glucose control (MD of −0.2%).74 
Another recent systematic review of 118 self-management 
interventions found improvements in HbA1c in 62% of 
studies. The overall mean effect was to reduce HbA1c 
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Figure 2D Effects of interventions on HbA1c, with baseline study quality subgroup.
by −0.57%, although patients with persistently elevated 
HbA1c over 9 had greater improvements.75 In our review, 
patient-orientated interventions, such as self-monitoring 
of blood glucose and self-management interventions, 
seemed to be less effective than organisational interven-
tions.
Case management by nurses and other professionals 
and case management in socially disadvantaged have 
been shown to be beneficial when targeted at all patients 
with T2DM and our review supports this conclusion for 
poorly controlled populations.5 76–78 Pharmacist-based 
interventions have been studied, mainly in outpatient 
settings or in US primary care and have been found 
to be effective and cost-effective.79 80 The five pharma-
cist interventions in our review, targeting patients with 
poorly controlled T2DM, showed mixed results, but 
overall had predominantly positive effects on HbA1c.
Attention to, and reporting of, intensification of antidi-
abetic medications and patient’s adherence to treatment 
regimens are needed to achieve optimal glycaemic 
control.81 82 Evidence regarding adherence in T2DM is 
mixed. A previous systematic review of 21 studies that 
included 14 RCTs to enhance T2DM treatment adherence 
in community and hospital settings found that few studies 
measured or assessed adherence and that interventions 
to improve adherence did not show benefits or harms.83 
A review by Farmer et al found limited evidence of effect 
for interventions promoting the monitoring of medi-
cation use and brief messaging to support medication 
adherence in patients with T2DM, though the included 
studies did not specifically target patients with poorly 
controlled diabetes.84 Only 10 of the 42 included studies 
in our review looked at adherence to medications as an 
outcome and only 2 of these 9 studies had a statistically 
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significant effect on adherence.49 62 The baseline level of 
adherence varied considerably and studies used different 
scale ranges.
Our review identified only one professional-based inter-
ventions in poorly controlled T2DM, through a physician 
decision aid.42 Two systematic reviews have examined the 
impact of clinical decision support systems (CDSS) on the 
management of T2DM in primary care, between them 
looking at 28 trials, with varying results but none of these 
CDSS interventions were designed to promote intensi-
fication of prescribing in persons with poor glycaemic 
control.85 86
Future research
There is a need for further research examining profes-
sional-based interventions in poorly controlled T2DM, 
such as CDSS, which promote intensification of medi-
cations.81 Studies from jurisdictions outside North 
America on poorly controlled populations would also be 
welcome. An individual patient data meta-analysis would 
answer further questions not possible in this review and 
future research should attempt to obtain individual-level 
patient data. It is likely that most successful interventions 
have their impact as a result of intensification of medi-
cines and/or improving adherence to medicines.81 As 
adherence was not measured in most of the studies and 
intensification poorly documented, it is important that 
future interventions report on these findings. Further-
more organisational interventions could incur significant 
costs to a health system, so cost-effectiveness analyses on 
future interventions should be undertaken to ensure the 
modest improvements in HbA1c are beneficial for the 
health systems.
In conclusion, clinicians and policy makers, when 
considering organisation of care for T2DM, should focus 
their effects on those patients with very poor glycaemic 
control (≥80 mmol/mol (9.5%)). Prioritising interven-
tions that emphasise structured organisation of care, 
which can include intensification and adherence to medi-
cations, also seem more likely to deliver optimal results in 
terms of glycaemic control for T2DM patients.
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